Ibuprofen Oral Suspension USP — Class II drug recall D-0531-2020
Terminated recall by Preferred Pharmaceuticals, Inc, reported 2019-12-04, distributed in CA, FL, IL. Presence of foreign substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic mate
| Recall number | D-0531-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Preferred Pharmaceuticals, Inc, Anaheim, CA, United States |
| Recall initiated | 2019-11-21 |
| Classified | 2019-11-27 |
| Reported by FDA | 2019-12-04 |
| Terminated | 2023-05-11 |
| Distributed | CA, FL, IL |
| NDC | 68788-7268-01 |
| Lot numbers | A2219E, C1519S, C2819Y, E2019V, I1718U, K0818L, L2718E |
| Expiration dates | 2020-03, 2020-09, 2020-11, 2020-12 |
Product
Ibuprofen Oral Suspension USP, 100 mg/5mL, 4 fl.oz. 118 mL, Rx only, Preferred Pharmaceuticals, Inc., Anaheim, CA. Mfg: Taro Pharm.; Hawthorne, NY; NDC 68788-7268-01
Reason for recall
Presence of foreign substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0531-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.